Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 300
Filter
1.
Rev. bioét. derecho ; (58): 93-108, Jul. 2023. graf, tab
Article in Spanish | IBECS | ID: ibc-222830

ABSTRACT

Se realizó un estudio exploratorio a través de una encuesta a Comités de Ética en países de América Latina y el Caribede habla hispana, con el fin de relevar su situación frente a emergencias sanitarias y consultar los dilemas éticos enfrentados en las investigaciones para COVID-19. Se obtuvieron respuestas de 106 comités, pertenecientes a 14 países.Solamente el 24% respondió que existía una red de comunicación eficiente y efectiva entre comités, previa a la pandemia. El 45% respondió queno existían en su región comités específicos para evaluar proyectos vinculados a emergencias sanitarias con anterioridad a la pandemia. El porcentaje de CEI que disponía de procedimientos previos para evaluar investigaciones en situaciones de emergencias sanitarias, fue sólo de 7%, si bien el 52% estaba en proceso de elaboración a raíz de la pandemia.El porcentaje de CEI que consideró razonable un tiempo inferior a 5 días para la evaluación de proyectos de investigación, varió en virtud del diseño: 32% para los estudios observacionales y 12% para los ensayos clínicos con drogas o con vacunas.Los tres problemas éticos principales identificados en los estudios para COVID estuvieron relacionados con el consentimiento informado, los aspectos metodológicos y la poca información previa o falta de evidencia para los productos de investigación.Consideramos que debemos reformular la manera de pensar los problemas éticos de las emergencias hacia un abordaje global, con un enfoque preventivo, donde las redes de colaboración entre los CEI deberían convertirse en regla.(AU)


Es va realitzar un estudi exploratori a través d'una enquesta a Comitès d'Ètica a països d'Amèrica Llatina i el Carib de parla hispana, per rellevar la seva situació davant d'emergències sanitàries i consultar els dilemes ètics enfrontats a les investigacions per a COVID-19. S'obtingueren respostes de 106 comitès, pertanyents a 14 països. Només el 24% va respondre que existia una xarxa de comunicació eficient i efectiva entre comitès, prèvia a la pandèmia. El 45% va respondre que no existien a la seva regió comitès específics per avaluar projectes vinculats a emergències sanitàries amb anterioritat a la pandèmia. El percentatge de CEI que disposava de procediments previs per avaluar investigacions en situacions d'emergències sanitàries va ser només de 7%, si bé el 52% estava en procés d'elaboració arran de la pandèmia. El percentatge de CEI que va considerar raonable un temps inferior a 5 dies per a l'avaluació de projectes de recerca va variar en virtut del disseny: 32% per als estudis observacionals i 12% per als assaigs clínics ambdrogues o amb vacunes.Els tres problemes ètics principals identificats als estudis per a COVID van estar relacionats amb el consentiment informat, els aspectes metodològics i la poca informació prèvia o manca d'evidència per als productes de recerca. Considerem que cal reformular la manera de pensar els problemes ètics de les emergències cap a un abordatge global, amb un enfocament preventiu, on les xarxes de col·laboració entre els CEI haurien de convertir-se en regla.(AU)


An exploratory study was carried out through a survey of Ethics Committees in Spanish-speaking Latin American and Caribbean countries, to assess their situation in the face of health emergencies and consult the ethical dilemmas faced in research for COVID-19. Responses were obtained from 106 committees, belonging to 14 countries.Only 24% responded that there was an efficient and effective communication network between committees, before the pandemic. 45% responded that there were no specific committees in their regions to evaluate projects linked to health emergencies before the pandemic. The percentage of RECs that had prior procedures to evaluate research in health emergencies was only 7%, although 52% were in the process of being prepared as a result of the pandemic.The percentage of RECs that reasonably expected less than 5 days to evaluate research projects varied by design: 32% for observational studies and 12% for clinical drug or vaccine trials.The three main ethical problems identified in the studies for COVID were related to informed consent, methodological aspects, and little prior information or lack of evidence for investigational products.We believe that we must reformulate the way of thinking about the ethical problems of emergencies towards a global approach, with a preventive approach, where collaboration networks between the RECs will not become the rule.(AU)


Subject(s)
Humans , Ethics, Medical , Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Pandemics/ethics , Pandemics/legislation & jurisprudence , Ethics Committees, Research , Bioethics , Bioethical Issues , Coronavirus Infections/epidemiology , Severe acute respiratory syndrome-related coronavirus
3.
Curr Opin Infect Dis ; 34(5): 393-400, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34342301

ABSTRACT

PURPOSE OF REVIEW: The COVID-19 pandemic is a global catastrophe that has led to untold suffering and death. Many previously identified policy challenges in planning for large epidemics and pandemics have been brought to the fore, and new ones have emerged. Here, we review key policy challenges and lessons learned from the COVID-19 pandemic in order to be better prepared for the future. RECENT FINDINGS: The most important challenges facing policymakers include financing outbreak preparedness and response in a complex political environment with limited resources, coordinating response efforts among a growing and diverse range of national and international actors, accurately assessing national outbreak preparedness, addressing the shortfall in the global health workforce, building surge capacity of both human and material resources, balancing investments in public health and curative services, building capacity for outbreak-related research and development, and reinforcing measures for infection prevention and control. SUMMARY: In recent years, numerous epidemics and pandemics have caused not only considerable loss of life, but billions of dollars of economic loss. The COVID-19 pandemic served as a wake-up call and led to the implementation of relevant policies and countermeasures. Nevertheless, many questions remain and much work to be done. Wise policies and approaches for outbreak control exist but will require the political will to implement them.


Subject(s)
COVID-19/prevention & control , Epidemics/legislation & jurisprudence , Epidemics/prevention & control , Pandemics/legislation & jurisprudence , Pandemics/prevention & control , Animals , Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Global Health/legislation & jurisprudence , Health Policy/legislation & jurisprudence , Health Workforce/legislation & jurisprudence , Humans , Public Health/legislation & jurisprudence
5.
Indian J Med Ethics ; VI(1): 1-10, 2021.
Article in English | MEDLINE | ID: mdl-34080990

ABSTRACT

Many states in India have invoked the provisions of the Epidemic Diseases Act, 1897, as a major tool in the fight against the Covid-19 pandemic. The current review attempts to discuss the ethical challenges in implementation of the Epidemic Diseases Act, 1897, to combat Covid-19 in India. Implementation of the Act in India has exposed its major limitations. It remains merely as a "policing" Act with no emphasis on coordinated and scientific responses to outbreaks and without provisions for protecting the rights of citizens. The Epidemic Diseases Act in its current form has the potential to cause more harm than good. Furthermore, the Epidemic Disease (Amendment) Bill, 2020, has not addressed any of these concerns. There is need for a rights-based, people-focused and public health-oriented law in India to deal with epidemics.


Subject(s)
COVID-19/prevention & control , Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Pandemics/legislation & jurisprudence , Pandemics/prevention & control , Public Health/ethics , Public Health/legislation & jurisprudence , COVID-19/epidemiology , Humans , India/epidemiology , SARS-CoV-2
6.
Eur J Health Law ; 28(1): 81-101, 2021 01 04.
Article in English | MEDLINE | ID: mdl-33652383

ABSTRACT

This article reflects on COVID-19 restrictions imposed on elders in Ireland through the lens of the right to private and family life (Article 8 ECHR), focusing on stay at home orders and recommendations advising elders to avoid social contact. Furthermore, we examine restrictions on visiting nursing homes given the high death toll in that setting. In our analysis, we zero in on the principles of foreseeability and proportionality, highlighting areas of concern and aspects that we submit should be considered in a proportionality assessment. Ultimately, we argue that it is a mistake to view the COVID-19 pandemic solely as an emergency. In this manner, the solutions suggested through the law - restrictions on movement and visitation bans - are too narrow and fail to address the underlying structures, such as, issues in the healthcare system, the limited home help for elderly and poor conditions in nursing homes.


Subject(s)
COVID-19/prevention & control , Disease Outbreaks/legislation & jurisprudence , Family , Patient Isolation/legislation & jurisprudence , Privacy , Visitors to Patients/legislation & jurisprudence , Aged , Freedom of Movement/legislation & jurisprudence , Homes for the Aged/standards , Humans , Ireland/epidemiology , Nursing Homes/standards
7.
J Prev Med Public Health ; 53(5): 293-301, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33070499

ABSTRACT

OBJECTIVES: At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, some countries imposed entry bans against Chinese visitors. We sought to identify the effects of border shutdowns on the spread of the COVID-19 outbreak. METHODS: We used the synthetic control method to measure the effects of entry bans against Chinese visitors on the cumulative number of confirmed cases using World Health Organization situation reports as the data source. The synthetic control method constructs a synthetic country that did not shut down its borders, but is similar in all other aspects. RESULTS: Six countries that shut down their borders were evaluated. For Australia, the effects of the policy began to appear 4 days after implementation, and the number of COVID-19 cases dropped by 94.4%. The border shutdown policy took around 13.2 days to show positive effects and lowered COVID-19 cases by 91.7% on average by the end of February. CONCLUSIONS: The border shutdowns in early February significantly reduced the spread of the virus. Our findings are informative for future planning of public health policies.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Health Policy/legislation & jurisprudence , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Travel/legislation & jurisprudence , Australia/epidemiology , COVID-19 , Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Hong Kong/epidemiology , Humans , Pandemics/legislation & jurisprudence , SARS-CoV-2 , Singapore/epidemiology , Taiwan/epidemiology , United States/epidemiology , Vietnam/epidemiology
8.
Emerg Infect Dis ; 26(9)2020 09.
Article in English | MEDLINE | ID: mdl-32620179

ABSTRACT

Israel's response during the containment phase of the COVID-19 outbreak in early 2020 led to a delay in sustained community transmission and effective mitigation. During February-April 2020, a total of 15,981 confirmed cases resulted in 223 deaths. A total of 179,003 persons reported electronically to self-quarantine and were entitled to paid sick leave.


Subject(s)
Coronavirus Infections/epidemiology , Disease Outbreaks/legislation & jurisprudence , Health Policy , Pandemics/legislation & jurisprudence , Pneumonia, Viral/epidemiology , Quarantine/legislation & jurisprudence , Betacoronavirus , COVID-19 , Coronavirus Infections/prevention & control , Humans , Israel/epidemiology , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Quarantine/methods , SARS-CoV-2 , Time Factors
9.
Bull Environ Contam Toxicol ; 105(1): 2-8, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32535674

ABSTRACT

As COVID-19 spread all over the world, most of the countries adopted some kind of restrictions to avoid the collapse of health systems. In Brazil, São Paulo and Rio the Janeiro, the two most populated cities in the country, were the first to determine social distancing. In this study, the impact of the social distancing measures on the concentrations of the three main primary air pollutants (PM10, NO2 and CO) was analyzed. CO levels showed the most significant reductions (up to 100%) since it is related to light-duty vehicular emissions. NO2 also showed reductions (9.1%-41.8%) while PM10 levels were only reduced in the 1st lockdown week. The decrease of pollutants was not directly proportional to the vehicular flux reduction, because it depends on other factors such as the transport of air masses from industrial and rural areas. The differences observed can be explained considering the fleet characteristics in the two cities and the response of the population to the social distancing recommendations.


Subject(s)
Air Pollution/analysis , Atmosphere/chemistry , Communicable Disease Control/statistics & numerical data , Disease Outbreaks/legislation & jurisprudence , Environmental Monitoring , Pandemics/statistics & numerical data , Betacoronavirus , Brazil , COVID-19 , Cities , Coronavirus Infections/prevention & control , Disease Outbreaks/prevention & control , Humans , Pandemics/prevention & control , Particulate Matter/analysis , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Vehicle Emissions/analysis
10.
Am J Public Health ; 110(8): 1145-1148, 2020 08.
Article in English | MEDLINE | ID: mdl-32437283

ABSTRACT

The World Health Organization (WHO) declared the COVID-19 virus outbreak to be a Public Health Emergency of International Concern on January 30, 2020. Although the Chinese central government implemented significant measures to control the epidemic from January 20 within China, the crisis had already escalated dramatically.Between December 1, 2019, and January 20, 2020, a total of 51 days passed before the Chinese central government took full control. Several major factors combined to cause what had been in retrospect a clear break in the governmental information chain between December 1 and January 20. The management of this epidemic also illustrated key organizational limitations of the current Chinese health system, in particular provincial-level senior officials' lack of knowledge and awareness of potential public health risks and insufficient emergency medical material storage and logistics arrangements.We review the specific disease control actions that the Chinese central government took between January 20 and January 27, the major reasons why the governmental information chain had broken before January 20, and key structural health system limitations highlighted as the epidemic expanded.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Policy , Public Health Administration/methods , Betacoronavirus , COVID-19 , China/epidemiology , Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Humans , Information Dissemination , Quarantine , SARS-CoV-2
14.
Multimedia | Multimedia Resources | ID: multimedia-3544

ABSTRACT

WHO Director-General's opening remarks at the technical briefing on 2019 novel coronavirus, 146th Session of the WHO Executive Board - February 4th, 2020


Subject(s)
Betacoronavirus , Pneumonia, Viral/transmission , Group Processes , Pneumonia, Viral/prevention & control , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Disease Outbreaks/legislation & jurisprudence , 50207
15.
Health Secur ; 18(S1): S105-S112, 2020 Jan.
Article in English | MEDLINE | ID: mdl-32004125

ABSTRACT

Long-standing cultural, economic, and political relationships among Benin, Nigeria, and Togo contribute to the complexity of their cross-border connectivity. The associated human movement increases the risk of international spread of communicable disease. The Benin and Togo ministries of health and the Nigeria Centre for Disease Control, in collaboration with the Abidjan Lagos Corridor Organization (a 5-country intergovernmental organization) and the US Centers for Disease Control and Prevention, sought to minimize the risk of cross-border outbreaks by defining and implementing procedures for binational and multinational public health collaboration. Through 2 multinational meetings, regular district-level binational meetings, and fieldwork to characterize population movement and connectivity patterns, the countries improved cross-border public health coordination. Across 3 sequential cross-border Lassa fever outbreaks identified in Benin or Togo between February 2017 and March 2019, the 3 countries improved their collection and sharing of patients' cross-border travel histories, shortened the time between case identification and cross-border information sharing, and streamlined multinational coordination during response efforts. Notably, they refined collaborative efforts using lessons learned from the January to March 2018 Benin outbreak, which had a 100% case fatality rate among the 5 laboratory-confirmed cases, 3 of whom migrated from Nigeria across porous borders when ill. Aligning countries' expectations for sharing public health information would assist in reducing the international spread of communicable diseases by facilitating coordinated preparedness and responses strategies. Additionally, these binational and multinational strategies could be made more effective by tailoring them to the unique cultural connections and population movement patterns in the region.


Subject(s)
Disease Outbreaks/prevention & control , International Cooperation , Lassa Fever/prevention & control , Travel , Benin , Centers for Disease Control and Prevention, U.S. , Disease Outbreaks/legislation & jurisprudence , Humans , Lassa Fever/epidemiology , Lassa Fever/mortality , Nigeria , Public Health Administration/legislation & jurisprudence , Public Health Administration/methods , Togo , United States
16.
Bull Hist Med ; 94(4): 590-601, 2020.
Article in English | MEDLINE | ID: mdl-33775941

ABSTRACT

This article applies the model developed in Charles Rosenberg's seminal article "What is an Epidemic?" to typhus outbreaks in eighteenth-century London. That framework remains valuable for understanding contagious disease in early modernity by helping to highlight the structure of responses to epidemics. So-called "Jail Fever" outbreaks are especially instructive, in part because the most notorious of these epidemics were small affairs when compared to the larger pandemics that Rosenberg explored. Considering that they accounted for relatively few deaths, historians must answer why they caused such a stir. Whereas the raw body count often drives development of narratives about epidemics, eighteenth-century typhus epidemics often hinged more on who died and where than how many. Typhus ravaged poor and working class communities throughout the period. However, even significant spikes in mortality occurring in poor neighborhoods often failed to trigger proclamations of epidemics. Some deaths mattered more than others in this regard, suggesting that qualitative criteria may have played a greater role than quantitative criteria when it came to identifying which events registered as epidemics in the eighteenth century.


Subject(s)
Disease Outbreaks/history , Typhus, Epidemic Louse-Borne/history , Disease Outbreaks/legislation & jurisprudence , History, 18th Century , Humans , London , Typhus, Epidemic Louse-Borne/epidemiology
17.
Curr Opin Pediatr ; 32(1): 160-166, 2020 02.
Article in English | MEDLINE | ID: mdl-31790028

ABSTRACT

PURPOSE OF REVIEW: This review summarizes the current state of school-entry vaccination requirements and related exemption policies in the United States and examines recent changes to these policies. RECENT FINDINGS: With recent infectious disease outbreaks in the United States, there has been heightened awareness on unvaccinated individuals, and the state-level policies that allow individuals to be exempted from school-entry vaccination requirements. Between 2015 and 2017, there have been eleven states that have altered their policies regarding school-entry vaccination requirements and related reporting for which no formal evaluations have been published. One policy change during that period, California SB 277, which became law in 2016, reduced the nonmedical exemption and increased the childhood vaccination coverage rate in that state, though with some evidence of exemption replacement through the use of medical exemptions. Through September 2019, five additional state law changes have been enacted. SUMMARY: The large number of heterogeneous changes to state-level policies for school-entry vaccination requirements in recent years need rigorous evaluation to identify best practices for balancing public health authority and parental autonomy while seeking to achieve the highest level of infectious disease prevention for children.


Subject(s)
Communicable Disease Control/methods , Disease Outbreaks/prevention & control , Health Policy/legislation & jurisprudence , Schools/legislation & jurisprudence , State Government , Vaccination/legislation & jurisprudence , Communicable Diseases/therapy , Disease Outbreaks/legislation & jurisprudence , Humans , Mandatory Programs/legislation & jurisprudence , Parenting , Personal Autonomy , Public Health/legislation & jurisprudence , United States
18.
Health Secur ; 17(6): 462-467, 2019.
Article in English | MEDLINE | ID: mdl-31800333

ABSTRACT

Laws are fundamental tools that regulate and manage various issues to protect the rights of the people in a society. Legislation on disease surveillance enables agencies to regulate and manage public health, including preventing the spread of infectious diseases. We assessed the Infectious Disease Prevention and Control Act of Korea (IDPCA) through the lens of biosurveillance to understand its effectiveness in protecting public health. In addition, the relevant legislation and regulations of the United States and the World Health Organization were examined. The evaluation concludes that the current IDPCA is limited in terms of providing guidance for early detection of and response to hazards using integrated data and an information-sharing system. Further revision of the laws is needed to enable early detection and warning of potential threats to public health.


Subject(s)
Biosurveillance/methods , Disease Outbreaks/prevention & control , Public Health/methods , Biosurveillance/legislation & jurisprudence , Disease Outbreaks/legislation & jurisprudence , Humans , Information Dissemination , Public Health/legislation & jurisprudence , Republic of Korea , United States , World Health Organization
19.
J Law Med Ethics ; 47(3): 412-426, 2019 09.
Article in English | MEDLINE | ID: mdl-31560619

ABSTRACT

Immunization plays a crucial role in global health security, preventing public health emergencies of international concern and protecting individuals from infectious disease outbreaks, yet these critical public health benefits are dependent on immunization law. Where public health law has become central to preventing, detecting, and responding to infectious disease, public health law reform is seen as necessary to implement the Global Health Security Agenda (GHSA). This article examines national immunization laws as a basis to implement the GHSA and promote the public's health, analyzing the scope and content of these laws to prevent infectious disease across Sub-Saharan Africa. Undertaking policy surveillance of national immunization laws in 20 Sub-Saharan African countries, this study: (1) developed a legal framework to map the legal attributes relevant to immunization; (2) created an assessment tool to determine the presence of these attributes under national immunization law; and (3) applied this assessment tool to code national legal landscapes. An analysis of these coded laws highlights legal attributes that govern vaccine requirements, supply chains, vaccine administration standards, and medicines quality and manufacturer liability. Based upon this international policy surveillance, it will be crucial to undertake legal epidemiology research across countries, examining the influence of immunization law on vaccination rates and disease outbreaks.


Subject(s)
Disease Outbreaks/legislation & jurisprudence , Disease Outbreaks/prevention & control , Global Health , Immunization/legislation & jurisprudence , Legal Epidemiology , Public Health/legislation & jurisprudence , Africa South of the Sahara/epidemiology , Humans
20.
J Law Med Ethics ; 47(2_suppl): 11-14, 2019 06.
Article in English | MEDLINE | ID: mdl-31298132

ABSTRACT

Laws and policies are vital tools in preventing outbreaks and limiting the further spread of disease, but they can vary in content and implementation. This manuscript provides insight into challenges in responding to recent vaccine-preventable disease outbreaks by examining legislative changes in California, policy changes on certain university campuses, and the laws implicated in a measles outbreak in Minnesota.


Subject(s)
Disease Outbreaks/legislation & jurisprudence , Vaccination/legislation & jurisprudence , Vaccine-Preventable Diseases/epidemiology , Adolescent , Child , Child, Preschool , Humans , Measles/epidemiology , Mumps/epidemiology , Students , United States/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...